Differentiated strategy of domestic pharmaceutical companies to catch Atozet

In the ezetimibe market represented by ‘Vytorin’ and ‘Atozet,’ domestic pharmaceutical companies have gotten ready to enter.

The pharmaceutical companies have tried to attract interests of the market by differentiating the complex in combination of ‘Crestor(rosuvastatin),’ which has not been launched so far,  from existing drugs

According to the Ministry of Food and Drug Safety on the 29^th, a...